AbbVie says Trump pressing for…
…
TRENDING
2.21 USD
0.0097 USD
0.1602 USD
2.16 USD
40.0081 USD
22.0 USD
0.0244 USD
8.51 USD
0.14 USD
0.12 USD
0.55 USD
0.0325 USD
38.4026 USD
119.5 USD
0.031 USD
2.11 USD
2.835 USD
4.55 USD
0.05 USD
1.17 USD
It’s a no for me, FDA rejects Biohaven’s (NYSE: BHVN) SCA treatment Biohaven (NYSE: BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA (troriluzole), rejecting its approval for spinocerebellar ataxia (SCA). The FDA cited concerns related to the real-world evidence study that formed the …